<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01205412</url>
  </required_header>
  <id_info>
    <org_study_id>112710</org_study_id>
    <nct_id>NCT01205412</nct_id>
  </id_info>
  <brief_title>An Observational Study on the Prevalence of Human Papillomavirus Types in Women in the Kingdom of Bahrain</brief_title>
  <official_title>An Observational, Epidemiological Study on the Prevalence of Human Papillomavirus (HPV) Types in Women in the Kingdom of Bahrain</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>GlaxoSmithKline</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>GlaxoSmithKline</source>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine the Human Papillomavirus (HPV) prevalence and HPV
      type distribution among women ≥ 20 years of age attending routine cervical screening and
      among women ≥ 16 years of age presenting for post-natal check up in the Kingdom of Bahrain.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>October 2010</start_date>
  <completion_date type="Actual">November 2011</completion_date>
  <primary_completion_date type="Actual">November 2011</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Prevalence of any Human Papillomavirus (HPV) deoxyribonucleic acid (DNA) and HPV type distribution among women undergoing cervical sample testing and post-natal check up.</measure>
    <time_frame>Average time frame: 12 months</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Prevalence of any HPV DNA and HPV type distribution among women of different age strata undergoing cervical sample testing and post-natal check up.</measure>
    <time_frame>Average time frame: 12 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Behavioural risk factors</measure>
    <time_frame>During visit 1 (day 0)</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Awareness of HPV in relation to transmission and cause of cervical cancer</measure>
    <time_frame>Average time frame: 12 months</time_frame>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Actual">552</enrollment>
  <condition>Human Papillomavirus Infection</condition>
  <arm_group>
    <arm_group_label>Assessed Cohort</arm_group_label>
    <description>Subjects attending out-patient health services for routine cervical screening or presenting for post-natal check up</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Endocervical samples</intervention_name>
    <description>Endocervical samples collection during routine gynaecological examinations</description>
    <arm_group_label>Assessed Cohort</arm_group_label>
  </intervention>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Endocervical samples
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Women ≥ 20 years of age, attending out-patient health services for routine cervical
        screening and women ≥ 16 years of age presenting for post-natal check up in the Kingdom of
        Bahrain.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Women ≥ 20 years of age attending a clinic for routine cervical screening OR

          -  Women ≥ 16 years of age presenting for post-natal check-ups

          -  Women providing a cervical sample

          -  Written informed consent or oral-witnessed thumb printed informed consent obtained
             from the subject

        Exclusion Criteria:

          -  Referral for abnormal cervical sample at the current visit

          -  Abundant menstrual bleeding or vaginal discharge not allowing appropriate screening to
             be performed (Note: Enrolment can be delayed until this condition is resolved)

          -  Pregnant women

          -  History of hysterectomy

          -  Known diagnosis of immunosuppression, or patient on immunosuppressives

          -  Having received one or more doses of human papillomavirus vaccine prior to
             participating in the study
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>16 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>GSK Clinical Trials</last_name>
    <role>Study Director</role>
    <affiliation>GlaxoSmithKline</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>GSK Investigational Site</name>
      <address>
        <city>Manama</city>
        <country>Bahrain</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Bahrain</country>
  </location_countries>
  <verification_date>November 2012</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 16, 2010</study_first_submitted>
  <study_first_submitted_qc>September 17, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 20, 2010</study_first_posted>
  <last_update_submitted>November 21, 2012</last_update_submitted>
  <last_update_submitted_qc>November 21, 2012</last_update_submitted_qc>
  <last_update_posted type="Estimate">November 22, 2012</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Papillomavirus Infections</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

